MYNZ
Income statement / Annual
Last year (2024), Mainz Biomed B.V.'s total revenue was $893,991.00,
a decrease of 0.17% from the previous year.
In 2024, Mainz Biomed B.V.'s net income was -$21.65 M.
See Mainz Biomed B.V.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$893,991.00 |
$895,479.00 |
$529,877.00 |
$577,348.00 |
$493,565.00 |
$281,393.00 |
| Cost of Revenue |
$319,108.00
|
$385,820.00
|
$347,726.00
|
$399,726.00
|
$370,480.00
|
$342,664.00
|
| Gross Profit |
$574,883.00
|
$509,659.00
|
$182,151.00
|
$177,622.00
|
$123,085.00
|
-$61,271.00
|
| Gross Profit Ratio |
0.64
|
0.57
|
0.34
|
0.31
|
0.25
|
-0.22
|
| Research and Development Expenses |
$5.84 M
|
$9.59 M
|
$3.66 M
|
$466,689.00
|
$311,851.00
|
$250,316.00
|
| General & Administrative Expenses |
$8.08 M
|
$13.42 M
|
$17.83 M
|
$8.45 M
|
$347,994.00
|
$388,785.00
|
| Selling & Marketing Expenses |
$4.70 M
|
$3.80 M
|
$4.98 M
|
$957,522.00
|
$110,380.00
|
$181,460.00
|
| Selling, General & Administrative Expenses |
$12.77 M
|
$17.22 M
|
$22.81 M
|
$9.41 M
|
$458,374.00
|
$570,245.00
|
| Other Expenses |
$656,336.00
|
$342,403.00
|
-$114,048.00
|
-$320,892.00
|
-$290,839.00
|
-$130,349.00
|
| Operating Expenses |
$19.27 M
|
$27.15 M
|
$26.36 M
|
$9.56 M
|
$479,386.00
|
$690,212.00
|
| Cost And Expenses |
$19.59 M
|
$27.54 M
|
$26.70 M
|
$9.96 M
|
$849,866.00
|
$1.03 M
|
| Interest Income |
$0.00
|
$0.00
|
$289,324.00
|
$339,171.00
|
$268,792.00
|
$201,936.00
|
| Interest Expense |
$1.08 M
|
$809,581.00
|
$289,324.00
|
$339,171.00
|
$268,792.00
|
$201,936.00
|
| Depreciation & Amortization |
$1.02 M
|
$1.03 M
|
$459,426.00
|
$209,903.00
|
$152,837.00
|
$53,042.00
|
| EBITDA |
-$19.56 M |
-$25.01 M |
-$25.72 M |
-$11.28 M |
-$257,641.00 |
-$702,077.00 |
| EBITDA Ratio |
-21.88
|
-27.93
|
-48.54
|
-19.54
|
-0.52
|
-2.5
|
| Operating Income Ratio |
-20.91
|
-29.75
|
-49.4
|
-16.25
|
-0.66
|
-3.28
|
| Total Other Income/Expenses Net |
-$2.96 M
|
$348,955.00
|
$56,704.00
|
-$1.97 M
|
-$261,084.00
|
-$35,146.00
|
| Income Before Tax |
-$21.65 M
|
-$26.30 M
|
-$26.39 M
|
-$11.70 M
|
-$586,895.00
|
-$957,055.00
|
| Income Before Tax Ratio |
-24.22
|
-29.36
|
-49.8
|
-20.26
|
-1.19
|
-3.4
|
| Income Tax Expense |
$0.00
|
$0.00
|
$65,389.00
|
$377,122.00
|
$299,282.00
|
$217,711.00
|
| Net Income |
-$21.65 M
|
-$26.30 M
|
-$26.45 M
|
-$12.07 M
|
-$886,177.00
|
-$1.17 M
|
| Net Income Ratio |
-24.22
|
-29.36
|
-49.92
|
-20.91
|
-1.8
|
-4.17
|
| EPS |
-22.36 |
-1.62 |
-1.87 |
-1.67 |
-0.16 |
-0.1 |
| EPS Diluted |
-22.36 |
-1.62 |
-1.87 |
-1.67 |
-0.16 |
-0.1 |
| Weighted Average Shares Out |
$968,234.00
|
$16.24 M
|
$14.16 M
|
$7.21 M
|
$5.61 M
|
$11.71 M
|
| Weighted Average Shares Out Diluted |
$968,234.00
|
$16.24 M
|
$14.16 M
|
$7.21 M
|
$5.61 M
|
$11.71 M
|
| Link |
|
|
|
|
|
|
